Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment

Cancer Diagnosis and Prognosis · Published 2026-07-01 · DOI 10.21873/cdp.10568

Free full text

Authors (17)

AKIHIRO FUJIMOTO, YUKI ICHINOSE, KAZUO MATSUURA, EMI MIKAMI, WAKAKO INOHANA, TAEKO KUROSAWA, AYAKO NAKAME, AYAKA SAKAKIBARA, ASAMI NUKUI, AYA ASANO, HIROKO SHIMADA, HIDEKI YOKOGAWA, MASAHIRO OHARA, HIROSHI ISHIGURO, TAKAHIRO HASEBE, AKIHIKO OSAKI, TOSHIAKI SAEKI

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

FUJIMOTO, A., ICHINOSE, Y., MATSUURA, K., et al. (2026). Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment. Cancer Diagnosis and Prognosis. https://doi.org/10.21873/cdp.10568

Related articles